Effects of urolithins on obesity-associated gut dysbiosis in rats fed on a high-fat diet

References

• Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, Adams RJ, Aekplakorn W, Afsana K, Aguilar-Salinas CA. 2017. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet. 390(10113):2627–2642.
   PubMed Web of Science ®Google Scholar
• Al-Assal K, Martinez AC, Torrinhas RS, Cardinelli C, Waitzberg D. 2018. Gut microbiota and obesity. Clin Nutr Exp. 20:60–64.
   Google Scholar
• Araújo JR, Tomas J, Brenner C, Sansonetti PJ. 2017. Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity. Biochimie. 141:97–106.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101(44):15718–15723.
   PubMed Web of Science ®Google Scholar
• Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ. 2000. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 66(4):1654–1661.
   PubMed Web of Science ®Google Scholar
• Bishara J, Farah R, Mograbi J, Khalaila W, Abu-Elheja O, Mahamid M, Nseir W. 2013. Obesity as a risk factor for Clostridium difficile infection. Clin Infect Dis. 57(4):489–493.
   PubMed Web of Science ®Google Scholar
• Boutagy NE, McMillan RP, Frisard MI, Hulver MW. 2016. Metabolic endotoxemia with obesity: is it real and is it relevant? Biochimie. 124:11–20.
   PubMed Web of Science ®Google Scholar
• Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. 2017. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction. Gastroenterology. 152(7):1671–1678.
   PubMed Web of Science ®Google Scholar
• Campbell CL, Yu R, Li F, Zhou Q, Chen D, Qi C, Yin Y, Sun J. 2019. Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice. Diabetes Metab Syndr Obes. 12(97):97–107.
   PubMedGoogle Scholar
• Canfora EE, Meex RC, Venema K, Blaak EE. 2019. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 15(5):261–273.
   PubMed Web of Science ®Google Scholar
• Carvalho FA, Koren O, Goodrich JK, Johansson MEV, Nalbantoglu I, Aitken JD, Su Y, Chassaing B, Walters WA, González A, et al. 2012. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe. 12(2):139–152.
   PubMed Web of Science ®Google Scholar
• Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. 2010. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. The Lancet. 376(9754):1775–1784.
   PubMed Web of Science ®Google Scholar
• Chen Y-T, Yang N-S, Lin Y-C, Ho S-T, Li K-Y, Lin J-S, Liu J-R, Chen M-J. 2018. A combination of Lactobacillus mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice. Sci Rep. 8(1):6153.
   PubMedGoogle Scholar
• Choi WJ, Dong HJ, Jeong HU, Ryu DW, Song SM, Kim YR, Jung HH, Kim TH, Kim Y-H. 2020. Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes. Sci Rep. 10(1):869.
   PubMed Web of Science ®Google Scholar
• Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, et al. 2013. Dietary intervention impact on gut microbial gene richness. Nature. 500(7464):585–588.
   PubMed Web of Science ®Google Scholar
• Cowan TE, Palmnäs MS, Yang J, Bomhof MR, Ardell KL, Reimer RA, Vogel HJ, Shearer J. 2014. Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics. J Nutr Biochem. 25(4):489–495.
   PubMed Web of Science ®Google Scholar
• Crascì L, Lauro MR, Puglisi G, Panico A. 2018. Natural antioxidant polyphenols on inflammation management: anti-glycation activity vs metalloproteinases inhibition. Crit Rev Food Sci Nutr. 58(6):893–904.
   PubMed Web of Science ®Google Scholar
• Cui C, Li Y, Gao H, Zhang H, Han J, Zhang D, Li Y, Zhou J, Lu C, Su X. 2017. Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice. PLoS One. 12(10):e0186216.
   PubMed Web of Science ®Google Scholar
• Del Chierico F, Nobili V, Vernocchi P, Russo A, De Stefanis C, Gnani D, Furlanello C, Zandonà A, Paci P, Capuani G, et al. 2017. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 65(2):451–464.
   PubMed Web of Science ®Google Scholar
• Ding S, Lund PK. 2011. Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care. 14(4):328–333.
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Neyrinck AM, Cani PD. 2013. Gut microbiota and metabolic disorders: how prebiotic can work? Br J Nutr. 109(S2):S81–S85.
   PubMedGoogle Scholar
• Dowd SE, Sun Y, Wolcott RD, Domingo A, Carroll JA. 2008. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis. 5(4):459–472.
   PubMed Web of Science ®Google Scholar
• Duda-Chodak A, Tarko T, Satora P, Sroka P. 2015. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur J Nutr. 54(3):325–341.
   PubMed Web of Science ®Google Scholar
• Eid HM, Wright ML, Anil Kumar N, Qawasmeh A, Hassan ST, Mocan A, Nabavi SM, Rastrelli L, Atanasov AG, Haddad PS. 2017. Significance of microbiota in obesity and metabolic diseases and the modulatory potential by medicinal plant and food ingredients. Front Pharmacol. 8:387.
   PubMed Web of Science ®Google Scholar
• Espín JC, Larrosa M, García-Conesa MT, Tomás-Barberán F. 2013. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013:1–15.
   Web of Science ®Google Scholar
• Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Muccioli GM, Neyrinck AM, Possemiers S, Van Holle A, François P, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 60(11):2775–2786.
   PubMed Web of Science ®Google Scholar
• Feng J, Tang H, Li M, Pang X, Wang L, Zhang M, Zhao Y, Zhang X, Shen J. 2014. The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults. Arch Microbiol. 196(1):73–77.
   PubMed Web of Science ®Google Scholar
• Fijan S. 2014. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health. 11(5):4745–4767.
   PubMed Web of Science ®Google Scholar
• Fleischman A, Shoelson SE, Bernier R, Goldfine AB. 2008. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 31(2):289–294.
   PubMed Web of Science ®Google Scholar
• Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 58(7):1509–1517.
   PubMed Web of Science ®Google Scholar
• Gérard P. 2016. Gut microbiota and obesity. Cell Mol Life Sci. 73(1):147–162.
   PubMed Web of Science ®Google Scholar
• Gomes AC, de Sousa RGM, Botelho PB, Gomes TLN, Prada PO, Mota JF. 2017. The additional effects of a probiotic mix on abdominal adiposity and antioxidant status: a double‐blind, randomized trial. Obesity. 25(1):30–38.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sarrias A, Garcia-Villalba R, Romo-Vaquero M, Alasalvar C, Orem A, Zafrilla P, Tomas-Barberan FA, Selma MV, Espin JC. 2017. Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: a randomized clinical trial. Mol Nutr Food Res. 61(5).
   Google Scholar
• González-Sarrías A, Giménez-Bastida JA, García-Conesa MT, Gómez-Sánchez MB, García-Talavera NV, Gil-Izquierdo A, Sánchez-Álvarez C, Fontana-Compiano LO, Morga-Egea JP, Pastor-Quirante FA. 2010. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol Nutr Food Res. 54(3):311–322.
   PubMed Web of Science ®Google Scholar
• Hernell O, West CE. 2013. Clinical effects of probiotics: scientific evidence from a paediatric perspective. Br J Nutr. 109(S2):S70–S75.
   Google Scholar
• Hong SJ, Lee J-H, Kim EJ, Yang HJ, Park J-S, Hong S-K. 2017. Anti-obesity and anti-diabetic effect of neoagarooligosaccharides on high-fat diet-induced obesity in mice. Mar Drugs. 15(4):90.
   Web of Science ®Google Scholar
• Johnson EL, Heaver SL, Walters WA, Ley RE. 2017. Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes. J Mol Med (Berl). 95(1):1–8.
   PubMed Web of Science ®Google Scholar
• Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T. 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 64(6):636–643.
   PubMed Web of Science ®Google Scholar
• Kameyama K, Itoh K. 2014. Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microb Environ. 29(4):427–430.
   PubMed Web of Science ®Google Scholar
• Kang I, Kim Y, Tomás-Barberán FA, Espín JC, Chung S. 2016. Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes. Mol Nutr Food Res. 60(5):1129–1138.
   PubMed Web of Science ®Google Scholar
• Kim J, Yun JM, Kim MK, Kwon O, Cho B. 2018. Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, placebo-controlled trial. J Med Food. 21(5):454–461.
   PubMed Web of Science ®Google Scholar
• Laursen MF, Laursen RP, Larnkjaer A, Molgaard C, Michaelsen KF, Frokiaer H, Bahl MI, Licht TR. 2017. Faecalibacterium gut colonization is accelerated by presence of older siblings. mSphere. 2(6):e00448-17.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen A-M, Peet A, Tillmann V, Pöhö P, Mattila I, et al. 2015. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 17(2):260–273.
   PubMed Web of Science ®Google Scholar
• Lee HC, Jenner AM, Low CS, Lee YK. 2006. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol. 157(9):876–884.
   PubMed Web of Science ®Google Scholar
• Li Q, Li K, Chen Z, Zhou B. 2020. Anti-renal fibrosis and anti-inflammation effect of urolithin B, ellagitannin-gut microbial-derived metabolites in unilateral ureteral obstruction rats. J Funct Foods. 65:103748.
   Web of Science ®Google Scholar
• Meehan CJ, Beiko RG. 2014. A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol Evol. 6(3):703–713.
   PubMed Web of Science ®Google Scholar
• Meijnikman AS, Gerdes VE, Nieuwdorp M, Herrema H. 2018. Evaluating causality of gut microbiota in obesity and diabetes in humans. Endocr Rev. 39(2):133–153.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M. 2011. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 62:361–380.
   PubMed Web of Science ®Google Scholar
• Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K, Ishikawa F. 2011. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol. 110(3):650–657.
   PubMed Web of Science ®Google Scholar
• Nirmalkar K, Murugesan S, Pizano-Zárate M, Villalobos-Flores L, García-González C, Morales-Hernández R, Nuñez-Hernández J, Hernández-Quiroz F, Romero-Figueroa M, Hernández-Guerrero C, et al. 2018. Gut microbiota and endothelial dysfunction markers in obese Mexican children and adolescents. Nutrients. 10(12):2009.
   Web of Science ®Google Scholar
• Pandey A, Bani S, Sangwan PL. 2014. Anti-obesity potential of gallic acid from Labisia pumila, through augmentation of adipokines in high fat diet induced obesity in C57BL/6 mice. Adv Res. 2(10):556–570.
   Google Scholar
• Paun A, Yau C, Danska JS. 2017. The influence of the microbiome on type 1 diabetes. J Immunol. 198(2):590–595.
   PubMed Web of Science ®Google Scholar
• Peng J, Narasimhan S, Marchesi JR, Benson A, Wong FS, Wen L. 2014. Long term effect of gut microbiota transfer on diabetes development. J Autoimmun. 53:85–94.
   PubMed Web of Science ®Google Scholar
• Queipo-Ortuño MI, Boto-Ordóñez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andrés-Lacueva C, Tinahones FJ. 2012. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. 95(6):1323–1334.
   PubMed Web of Science ®Google Scholar
• Rather IA, Bajpai VK, Ching LL, Majumder R, Nam G-J, Indugu N, Singh P, Kumar S, Hajrah NH, Sabir JSM, et al. 2020. Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model. Saudi J Biol Sci. 27(1):261–270.
   PubMed Web of Science ®Google Scholar
• Reid G. 1999. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol. 65(9):3763–3766.
   PubMed Web of Science ®Google Scholar
• Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F. 2014. The prokaryotes: actinobacteria. Springer. https://doi.org/10.1007/978-3-642-30138-4.
   Google Scholar
• Savi M, Bocchi L, Mena P, Dall’Asta M, Crozier A, Brighenti F, Stilli D, Del Rio D. 2017. In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 16(1):1–13.
   PubMedGoogle Scholar
• Shen J, Obin MS, Zhao L. 2013. The gut microbiota, obesity and insulin resistance. Mol Aspects Med. 34(1):39–58.
   PubMed Web of Science ®Google Scholar
• Singh AK, Bishayee A, Pandey AK. 2018. Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy. Nutrients. 10(6):731.
   PubMed Web of Science ®Google Scholar
• Smith AH, Mackie RI. 2004. Effect of condensed tannins on bacterial diversity and metabolic activity in the rat gastrointestinal tract. Appl Environ Microbiol. 70(2):1104–1115.
   PubMed Web of Science ®Google Scholar
• Stenman LK, Holma R, Eggert A, Korpela R. 2013. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol. 304(3):G227–G234.
   PubMed Web of Science ®Google Scholar
• Tanida M, Shen J, Maeda K, Horii Y, Yamano T, Fukushima Y, Nagai K. 2008. High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes Res Clin Pract. 2(3):I–II.
   PubMed Web of Science ®Google Scholar
• Tomás-Barberán FA, González-Sarrías A, García-Villalba R, Núñez-Sánchez MA, Selma MV, García-Conesa MT, Espín JC. 2017. Urolithins, the rescue of “old” metabolites to understand a “new” concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res. 61(1):1500901.
   Web of Science ®Google Scholar
• Wang J, Wang P, Li D, Hu X, Chen F. 2020. Beneficial effects of ginger on prevention of obesity through modulation of gut microbiota in mice. Eur J Nutr. 59(2):699–718.
   PubMed Web of Science ®Google Scholar
• Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, Wang Y, Liu C, Wang W, Wang J, et al. 2019. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 26(1):222–235.e225.
   PubMed Web of Science ®Google Scholar
• Woods SC, Seeley RJ, Rushing PA, D'Alessio D, Tso P. 2003. A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 133(4):1081–1087.
   PubMed Web of Science ®Google Scholar
• Wu C-C, Weng W-L, Lai W-L, Tsai H-P, Liu W-H, Lee M-H, Tsai Y-C. 2015. Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid Based Complement Alternat Med. 2015:391767.
   PubMed Web of Science ®Google Scholar
• Wu T-R, Lin C-S, Chang C-J, Lin T-L, Martel J, Ko Y-F, Ojcius DM, Lu C-C, Young JD, Lai H-C. 2019. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 68(2):248–262.
   PubMed Web of Science ®Google Scholar
• Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M, et al. 2014. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol. 87(2):357–367.
   PubMed Web of Science ®Google Scholar
• Xin J, Zeng D, Wang H, Ni X, Yi D, Pan K, Jing B. 2014. Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. Appl Microbiol Biotechnol. 98(15):6817–6829.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Adachi K, Sugiyama T, Shimozato A, Ebi M, Ogasawara N, Funaki Y, Goto C, Sasaki M, Kasugai K. 2016. Association of intestinal microbiota with metabolic markers and dietary habits in patients with type 2 diabetes. Digestion. 94(2):66–72.
   PubMed Web of Science ®Google Scholar
• Yang C, Li L, Yang L, Lǚ H, Wang S, Sun G. 2018. Anti-obesity and hypolipidemic effects of garlic oil and onion oil in rats fed a high-fat diet. Nutr Metab (Lond). 15(1):43.
   PubMedGoogle Scholar
• Zhang J, Yang G, Wen Y, Liu S, Li C, Yang R, Li W. 2017. Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide. Mol Nutr Food Res. 61(11):1700466.
   Web of Science ®Google Scholar
• Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L. 2015. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep. 5:14405.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang L, Haller V, Ritsch A. 2019. A novel candidate for prevention and treatment of atherosclerosis: urolithin B decreases lipid plaque deposition in apoE−/− mice and increases early stages of reverse cholesterol transport in ox‐LDL treated macrophages cells. Mol Nutr Food Res. 63(10):1800887.
   Web of Science ®Google Scholar